OMX30 1 617 0,5%  OMXH25 3 931 1,1%  OMXC20 945 0,6%  Dow 20 996 1,1%  Nas 5 548 0,7%  EUR 9,5897 0,1%  USD 8,7608 -0,1%  Olja 52,1 0,2%  Guld 1 264 0,1% 

Smith & Nephew Aktie

12,69GBP 0,08GBP 0,63%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Smith & Nephew

2016 2017e 2018e 2019e 2020e
Utdelning 0,25 0,26 0,28 0,30 0,34
Direktavkastning (i %) 2,10 2,00 2,17 2,32 2,63
PE-tal 17,87 19,33 18,12 16,28 14,32
Resultat/aktie 0,67 0,66 0,71 0,79 0,89
ytterligare nyheter

Analyser om Smith & Nephew plc

ytterligare analyser

Smith & Nephew Peer Group

Fresenius Medical Care 81,54
0,3%
Fresenius 74,39
-1,5%
Intuitive Surgical 827,25
0,6%
STRATEC Biomedical 53,20
-3,2%
Smith & Nephew 12,69
0,6%
Stryker 135,71
1,0%
Zimmer Biomet 124,48
1,0%
pagehit

Lägg till instrument

Vad tycker du?

Profil Smith & Nephew plctill bolagsprofilen

Smith & Nephew Plc is a global orthopedics company. It develops, manufactures, markets and sells medical devices in the sectors of advanced medical devices and advanced wound management. The company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. Advanced Surgical Devices offers the following products and technologies: Orthopaedic Reconstruction, Trauma & Extremities, Sports Medicine Joint Repair, Arthroscopy and Other ASD. Orthopaedic Reconstruction includes Hip Implants, Knee Implants and ancillary products such as bone cement and mixing systems used in cemented reconstruction joint surgery. Trauma & Extremities consists of internal and external devices used in the stabilization of severe fractures and deformity correction procedures. Sports Medicine Joint Repair offers surgeons a broad array of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints. Arthroscopy Enabling Technologies offer healthcare providers a variety of technologies such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources and monitors to assist with visualization inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue. Other ASD includes gynaecological instrumentation and the remaining Clinical Therapies geographies which are in the process of being transferred to Bioventus. Advanced Wound Management's products include Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives. Advanced Wound Care includes products for the treatment of acute and chronic wounds, including leg, diabetic and pressure ulcers, burns and post-operative wounds. Advanced Wound Devices consists of traditional and single-use Negative Pressure Wound Therapy and hydrosurgery systems. Advanced Wound Bioactives include biologics and other bioactive technologies that provide unique approaches to debridement and dermal repair/regeneration. Smith & Nephew was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.

Aktiekurs Smith & Nephew plc i GBPPUSH CHART

Kurs 12,69 GBP 0,08 0,63 %
Kurstid 17:35:16
Datum 25.04.2017
Öppning 0,00
Gårdagen 12,69
Dagshögsta 0,00
Dagslägsta 0,00
52 v. högsta 13,24
52 v. lägsta 10,65
52 v. perf.
Volym (Antal) 0
Börsvärde (SEK) 123,92 Mrd
Börsen
Kurs för 12,69 GBP från börsen London motsvarar med aktuell växelkurssentspricht GBP/SEK en kurs på 142,75 SEK.

Till aktien Smith & Nephew

Ticker
ISIN GB0009223206
Index FTSE 100, FTSE Allshare

Smith & Nephew Nyckeltal

Börsvärde i SEK 123,92 Mrd
Free float % 98,73
Antal aktier mio. 875,06
Cashflow/aktie i lokal valuta 0,79
Bokvärde/aktie i lokal valuta 3,60
60 dagar vola 30,06
PBV 3,31

Smith & Nephew Historiska kurser

2017-04-25 12,69 2 503 159
2017-04-24 12,61 2 473 407
2017-04-21 12,38 2 621 586
2017-04-20 12,28 2 199 236
2017-04-19 12,28 1 893 900